VA Greater Los Angeles Healthcare System, West LA
West Los Angeles, California, 90073, United States
NCT Number: NCT00108173
The purpose of the study was to determine how the treatments for cigarette craving work.
Hypothesis: During exposure to cigarette-related cues, heavy smokers will have greater reductions in regional brain activation from before to after both forms of active treatments than from before to after placebo.
Looking for future studies?
Notify Me21 year–60 year
All sexes
Interventional
Phase 1
West Los Angeles, California, 90073, United States
PET and fMRI scanning were used to examine brain activity and activation in cigarette smokers in response to cigarette-related cues.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Drug or alcohol dependence Mental Illness Pregnancy Medications that affect brain function Unstable medical conditions
Time frame: Within the first few weeks of study initiation
Brain activity and activation in response to cigarette-related cues
US Department of Veterans Affairs
Fed
Neural Substrates of Treatment for Nicotine Dependence
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07737288
Behavior, Chemically-Induced Disorders
Izmir, Turkey (Türkiye)
View Trial DetailsNCT01036685
Chemically-Induced Disorders, Drug Abuse
Baltimore, Maryland, United States
View Trial DetailsNCT01867411
Behavior, Chemically-Induced Disorders
Baltimore, Maryland, United States
View Trial DetailsNCT04188873
Chemically-Induced Disorders, Mental Disorders
Madison, Wisconsin, United States
View Trial Details